A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
Clinical trial NCT05811000 · UNKNOWN
Trial details
- NCT number
- NCT05811000
- Sponsor
- Mediforum Ltd., Co.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-02-24
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.